• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
India Pharmaceuticals and Healthcare Report Q2 2008 - Product Image

India Pharmaceuticals and Healthcare Report Q2 2008

  • ID: 597802
  • March 2008
  • Region: India
  • 101 pages
  • Business Monitor International

FEATURED COMPANIES

  • Aurobindo Pharmaceutical
  • Dr Reddy’s Laboratories
  • GlaxoSmithKline (GSK)
  • Merck & Co
  • Novartis
  • Ranbaxy Laboratories
  • MORE

The India Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Indias pharmaceuticals and healthcare industry.

BMI’s regional Business Environment Rankings table for Q2 208 once again ranks India as a moderately attractive proposition to multinational pharmaceutical companies operating in the Asia Pacific. Along with Malaysia, India is placed at a joint eighth position.. While its market size and annual growth indicators are viewed as some of the key attractions, India still suffers from the disadvantage of excessive red tape, an underdeveloped infrastructure, deficiency of legal framework, low per capita spending, and a large rural and poor population.

In addition, deficiencies in regulatory, intellectual property (IP) and pricing environments remain as barriers to investment. The Indian generic companies are defending themselves from costly patent litigation from a number of prominent multinationals, including Novartis and Roche. The latter, which filed a patent infringement suit against Cipla in January 2008, is in fact already involved in a patent suit with Ranbaxy Laboratories. On the other hand, a December 2007 READ MORE >

FEATURED COMPANIES

  • Aurobindo Pharmaceutical
  • Dr Reddy’s Laboratories
  • GlaxoSmithKline (GSK)
  • Merck & Co
  • Novartis
  • Ranbaxy Laboratories
  • MORE

Executive Summary
India Pharmaceutical Industry SWOT
India Political SWOT
India Economic SWOT
India Business Environment SWOT

India’s Pharmaceutical Business Environment Ratings
Table: Asia Pacific Pharmaceutical Business Environment Rankings For Q208
Limits Of Potential Returns
Risks To Realisation Of Returns

Market Summary
Regulatory Environment
Pharmacovigilance
Recent Regulatory Developments
IP Regime
Table: History Of The Indian Patent System
Deficiencies of IP Regime
Recent IP Developments
Patent Disputes
Counterfeit Medicines
Table: Anti-Counterfeiting Guidelines From The Organisation Of Pharmaceutical Producers Of India (OPPI)
Pricing And Reimbursement
Other Regulatory Developments

Industry Trends And Developments
Epidemiology
Healthcare Sector
Pharmaceutical Industry
Domestic Industry Developments
Foreign Company Developments
Retail Pharmacy Sector
Table: Major Players In Indias Retail Pharmacy Sector

Foreign Co-operation
Table: India - Asian FTA Situation
Clinical Research
Table: Clinical Trial Considerations In Asia
Active Pharmaceutical Ingredients
Table: APIs Manufactured By Hikal

Biotechnology Sector
Recent Biotechnology Sector Developments
Medical Devices
Industry Forecast Scenario
Overall Market Forecast
Table: Drug Expenditure and Prescription Market Indicators (US$mn unless otherwise staed)
Key Growth Factors - Industry
Table: India - Health Expenditure Forecasts
Key Growth Factors - Macroeconomic
Table: India - Economic Activity
Patented Market Forecast
Table: India Patented Forecasts (US$mn unless otherwise stated)
Generics Market Forecast
Table: India Generics And Branded Market Forecast Indicators
OTC Market Forecast
Table: India - OTC Market Forecasts (US$mn unless otherwise stated)
Export/Import Forecasts
Table: India Imports And Exports Forecasts (US$bn)
Other Healthcare Data Forecasts
Table: India Healthcare Data Forecasts
Key Risks To our Forecast Scenario
Competitive Landscape.56
Table: Ranking Of Indian Drug-makers By Retail Sales, July 2007

Company Profiles

Leading Multinational Manufacturers
- Pfizer
- GlaxoSmithKline (GSK)
- Novartis
- Sanofi-Aventis
- Merck & Co
- Eili Lilly

Leading Indigenous Manufacturers
- Ranbaxy Laboratories
- Cipla
- Dr Reddy’s Laboratories
- Aurobindo Pharmaceutical
- Venus Remedies
- Granules India
- Nicholas Piramal India
- Zydus Cadila
- Dishman Pharmaceuticals and Chemicals

BMI Forecast Modelling
How We Generate Our Industry Forecasts
Pharmaceutical Industry
Pharmaceutical Business Environment Ratings Methodology
Ratings Overview
Table: Pharmaceutical Business Environment Indicators
Sources 0



- Pfizer
- GlaxoSmithKline (GSK)
- Novartis
- Sanofi-Aventis
- Merck & Co
- Eili Lilly
- Ranbaxy Laboratories
- Cipla
- Dr Reddy’s Laboratories
- Aurobindo Pharmaceutical
- Venus Remedies
- Granules India
- Nicholas Piramal India
- Zydus Cadila
- Dishman Pharmaceuticals and Chemicals

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos